Consistent with a hypothesis of compensatory downregulation of EZH2 in early prostate tumorigenesis, the positive correlation between INPP4B and EZH2 is only evident in the primary prostate tumors (Figure 2e). The gene discussed is EZH2; the disease is prostate neoplasm.